A systematic review explores how AI-based clinical decision support systems can enhance cardiovascular disease management while facing adoption and equity challenges.
Key Details
- 1Research from Flinders University reviews AI's role in cardiovascular care through CDSS.
- 2Study identifies workflow integration, usability, and workforce readiness as key barriers to adoption.
- 3Out of 700+ studies, 12 large, global studies were deeply assessed.
- 4Strong governance, organisational support, and regulatory alignment are crucial for sustainable AI implementation.
- 5AI systems could reduce diagnosis delays and improve care in underserved, rural settings.
- 6Equity issues persist due to potential dataset bias and lack of AI-integrated prevention protocols.
Why It Matters
There is significant promise for AI-driven CDSS to improve cardiovascular care management, which can inform implementation in radiology and related imaging fields. Understanding barriers to adoption, governance needs, and equity issues can help the radiology-AI community advance safe, effective, and equitable integration of AI tools.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.